Clinical Trial Update: Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing daunorubicin and cytarabine (DA) versus mitoxantrone with intermittent cytarabine in patients over 60 with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Leukemia, Nonlymphocytic, Acute | Phase 4 | Status: COMPLETED